Cargando…
Effect of Levocarnitine on the Therapeutic Efficacy of Conventional Therapy in Children with Dilated Cardiomyopathy: Results of a Randomized Trial in 29 Children
BACKGROUND: The effect of levocarnitine supplementation has not been evaluated in children with dilated cardiomyopathy (DCM). OBJECTIVE: The aim of this study was to explore the effect of oral levocarnitine supplementation in pediatric patients with DCM. METHODS: Twenty-nine children with DCM (17 ma...
Autores principales: | Wang, Yuwen, Xu, Yi, Zou, Runmei, Wu, Lijia, Liu, Ping, Yang, Hong, Xie, Zhenwu, Wang, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954011/ https://www.ncbi.nlm.nih.gov/pubmed/29468383 http://dx.doi.org/10.1007/s40272-018-0284-2 |
Ejemplares similares
-
Predictive value of electrocardiographic markers in children with dilated cardiomyopathy
por: Wang, Miao, et al.
Publicado: (2022) -
The Changes of T-Wave Amplitude and QT Interval Between the Supine and Orthostatic Electrocardiogram in Children With Dilated Cardiomyopathy
por: Tan, Cheng, et al.
Publicado: (2021) -
Significance of Levocarnitine Treatment in Dialysis Patients
por: Takashima, Hiroyuki, et al.
Publicado: (2021) -
Levocarnitine for pegaspargase‐induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia
por: Schulte, Rachael, et al.
Publicado: (2021) -
Feasibility of the Omaha system for the care of children with dilated cardiomyopathy
por: Zhang, Qin, et al.
Publicado: (2023)